A combined pretreatment of 1,25-dihydroxyvitamin D3 and sodium valproate enhances the damaging effect of ionizing radiation on prostate cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 391-394

  Gavrilov, Vladimir ^a   Leibovich, Yaron ^b   Ariad, Samuel ^b   Lavrenkov, Konstantin ^b   Shany, Shraga ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

1,25 Dihydroxyvitamin D3; Histone deacetylase inhibitor; Ionizing radiation; Prostate cancer; Sodium valproate

Indexed keywords

CALCITRIOL; DOUBLE STRANDED DNA; HISTONE; VALPROIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER PATIENT; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; HUMAN; HUMAN CELL; IONIZING RADIATION; MALE; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; RADIATION DOSE; CELL CYCLE; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

APOPTOSIS; CALCITRIOL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION, IONIZING; VALPROIC ACID;

EID: 77954758657     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.004     Document Type: Article

References (17)

1. Lankford S.P., Pollack A., Zagars G.K. Radiotherapy for regionally localized hormone-refractory prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33(4):907-912.
2. Akimoto T., Kitamoto Y., Saito J., Harashima K., Nakano T., Ito K., Yamamoto T., Kurokawa K., Yamanaka H., Takahashi M., Mitsuhashi N., Nibe H. External beam radiotherapy for clinically node-negative, localized hormone refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59(2):372-379.
3. Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., von Eschenbach A.C., Kuban D.A., Rosen I. Prostate cancer radiation dose response: results of the MD Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 2002, 53(5):1097-1105.
4. Wu C.T., Chen W.C., Liao S.K., Hsu C.L., Lee K.D., Chen M.F. The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy. Endoctin. Relat. Cancer 2007, 14(3):633-643.
5. Dunlap N., Schwartz G.G., Eads D., Cramer S.D., Sherk A.B., John V., Koumenis C. 1alpha, 25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha, 25(OH)(2)D(2), potentiate the effects of ionizing radiation on human prostate cancer cells. Br. J. Cancer 2003, 89(4):746-753.
6. Camphausen K., Cerna D., Scott T., Sproull M., Burgan W.E., Cerra M.A., Fine H., Tofilon P.J. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid. Int. J. Cancer 2005, 114(3):380-386.
7. Rothkamm K., Krüger I., Thompson L., Löbrich M. Pathways of DNA double-strand breaks repair during the mammalian cell cycle. Mol. Cell. Biol. 2003, 23(16):5706-5715.
8. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408(6811):433-439.
9. Kueng W., Silber E., Eppenberger U. Quantification of cells cultured on 96-well plates. Anal. Biochem. 1989, 182(1):16-19.
10. Senaratne S.G., Pirianov G., Mansi J.L., et al. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br. J. Cancer 2000, 82(8):1459-1468.
11. Darzynkiewicz Z., Juan G., Bedner E. Determining cell cycle stages by flow cytometry. Curr. Protoc. Cell Biol. 2001, (Chapter 8): Unit 8.4.
12. NIH Chemical Genomics Center-Assay Guidance-cell-based Elisa (C-Elisa) and Westerns Blots for quantitative antigen detection. http://www.ncgc.nih.gov/guidance/section7.html.
13. Kinner A., Wu W., Staudt C., Iliakis G. γ-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acid Res. 2008, 36(17):5678-5694.
14. Chen C.S., Wang Y.C., Yang H.C., Huang P.H., Kulp S.K., Yang C.C., Lu Y.S., Matsuyama S., Chen C.Y., Chen C.S. Histone deacetylase inhibitors sensitize prostate cancer cells to agent that produce DNA double-strand breaks by targeting Ku70 acetylation. Cancer Res. 2007, 67(11):5318-5327.
15. Louis M., Rosato R.R., Brault L., Osbild S., Battaglia E., Yang X.H., Grant S., Bagrel D. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int. J. Oncol. 2004, 25(6):1701-1711.
16. Falck J., Mailand N., Syljuåsen R.G., Bartek J., Lucas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410(6830):842-847.
17. Ernst D.S. The role of chemotherapy in advanced prostate cancer. Can. J. Urol. 2002, 9(suppl. 1):21-25.